Validation of a [Al18F]PSMA-11 preparation for clinical applications-Reference-Cited by-同舟云学术

Validation of a [Al18F]PSMA-11 preparation for clinical applications

Published:2017-12 Issue: Volume:130 Page:102-108
ISSN:0969-8043
Container-title:Applied Radiation and Isotopes
language:en
Short-container-title:Applied Radiation and Isotopes

Author:

Al-Momani Ehab,Israel Ina,Samnick Samuel

Publisher

Elsevier BV

Subject

Radiation

Reference30 articles.

1. [68Ga] Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH;Afshar-Oromieh;Eur. J. Nucl. Med. Mol. Imaging,2012

2. Characterization of the aluminum and beryllium fluoride species which activate transducin. Analysis of the binding and dissociation kinetics;Antonny;J. Biol. Chem.,1992

3. Radionuclide and hybrid imaging of recurrent prostate cancer;Beer;Lancet Oncol.,2011

4. 68Ga-PSMA-PET/CT in patients with biochemical prostate cancer recurrence and negative 18F-Choline-PET/CT;Bluemel;Clin. Nucl. Med.,2016

5. Synthesis and preclinical evaluation of an Al18F radiofluorinated GLU-UREA-LYS (AHX)-HBED-CC PSMA ligand;Boschi;Eur. J. Nucl. Med. Mol. Imaging,2016

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method;EJNMMI Radiopharmacy and Chemistry;2024-06-21

2. Optimization and scale up of production of the PSMA imaging agent [18F]AlF-P16-093 on a custom automated radiosynthesis platform;EJNMMI Radiopharmacy and Chemistry;2024-02-23

3. A systematic review on the current status of PSMA-targeted imaging and radioligand therapy;European Journal of Medicinal Chemistry;2024-01

4. Radiochemistry with {Al18F}2+: Current status and optimization perspectives for efficient radiofluorination by complexation;Coordination Chemistry Reviews;2023-04

5. Al[18F]F-HBED-CC-radiolabeling in a media of protic alkanolammonium ionic liquids;Mendeleev Communications;2022-05